Cargando…

Production and Characterization of ACE Inhibitory and Anti-Diabetic Peptides from Buffalo and Camel Milk Fermented with Lactobacillus and Yeast: A Comparative Analysis with In Vitro, In Silico, and Molecular Interaction Study

The investigation aimed at assessing a comparative study on the production and characterization of ACE inhibitory, anti-diabetic, and anti-inflammatory activities, along with the production of ACE inhibitory and anti-diabetic peptides through the fermentation of buffalo and camel milk by Limosilacto...

Descripción completa

Detalles Bibliográficos
Autores principales: Khakhariya, Ruchita, Basaiawmoit, Bethsheba, Sakure, Amar A., Maurya, Ruchika, Bishnoi, Mahendra, Kondepudi, Kanthi Kiran, Padhi, Srichandan, Rai, Amit Kumar, Liu, Zhenbin, Hati, Subrota
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216992/
https://www.ncbi.nlm.nih.gov/pubmed/37238823
http://dx.doi.org/10.3390/foods12102006
_version_ 1785048429082181632
author Khakhariya, Ruchita
Basaiawmoit, Bethsheba
Sakure, Amar A.
Maurya, Ruchika
Bishnoi, Mahendra
Kondepudi, Kanthi Kiran
Padhi, Srichandan
Rai, Amit Kumar
Liu, Zhenbin
Hati, Subrota
author_facet Khakhariya, Ruchita
Basaiawmoit, Bethsheba
Sakure, Amar A.
Maurya, Ruchika
Bishnoi, Mahendra
Kondepudi, Kanthi Kiran
Padhi, Srichandan
Rai, Amit Kumar
Liu, Zhenbin
Hati, Subrota
author_sort Khakhariya, Ruchita
collection PubMed
description The investigation aimed at assessing a comparative study on the production and characterization of ACE inhibitory, anti-diabetic, and anti-inflammatory activities, along with the production of ACE inhibitory and anti-diabetic peptides through the fermentation of buffalo and camel milk by Limosilactobacillus fermentum (KGL4) and Saccharomyces cerevisiae (WBS2A). The angiotensin-converting enzyme (ACE) inhibitory and anti-diabetic properties were evaluated at particular time intervals (12, 24, 36, and 48 h) at 37 °C, and we discovered maximum activity at 37 °C after 48 h of incubation. The maximum ACE inhibitory, lipase inhibitory activities, alpha-glucosidase inhibitory, and alpha-amylase inhibitory activities were found in the fermented camel milk (77.96 ± 2.61, 73.85 ± 1.19, 85.37 ± 2.15, and 70.86 ± 1.02), as compared to the fermented buffalo milk (FBM) (75.25 ± 1.72, 61.79 ± 2.14, 80.09 ± 0.51, and 67.29 ± 1.75). Proteolytic activity was measured with different inoculation rates (1.5%, 2.0%, and 2.5%) and incubation times (12, 24, 36, and 48 h) to optimize the growth conditions. Maximum proteolysis was found at a 2.5% inoculation rate and at a 48 h incubation period in both fermented buffalo (9.14 ± 0.06) and camel milk (9.10 ± 0.17). SDS-PAGE and 2D gel electrophoresis were conducted for protein purification. The camel and buffalo milk that had not been fermented revealed protein bands ranging from 10 to 100 kDa and 10 to 75 kDa, respectively, whereas all the fermented samples showed bands ranging from 10 to 75 kDa. There were no visible protein bands in the permeates on SDS-PAGE. When fermented buffalo and camel milk were electrophoresed in 2D gel, 15 and 20 protein spots were detected, respectively. The protein spots in the 2D gel electrophoresis ranged in size from 20 to 75 kDa. To distinguish between different peptide fractions, water-soluble extract (WSE) fractions of ultrafiltration (3 and 10 kDa retentate and permeate) of fermented camel and buffalo milk were employed in RP-HPLC (reversed-phase high-performance liquid chromatography). The impact of fermented buffalo and camel milk on inflammation induced by LPS (lipopolysaccharide) was also investigated in the RAW 264.7 cell line. Novel peptide sequences with ACE inhibitory and anti-diabetic properties were also analyzed on the anti-hypertensive database (AHTDB) and bioactive peptide (BIOPEP) database. We found the sequences SCQAQPTTMTR, EMPFPK, TTMPLW, HPHPHLSFMAIPPK, FFNDKIAK, ALPMHIR, IPAVFK, LDQWLCEK, and AVPYPQR from the fermented buffalo milk and the sequences TDVMPQWW, EKTFLLYSCPHR, SSHPYLEQLY, IDSGLYLGSNYITAIR, and FDEFLSQSCAPGSDPR from the fermented camel milk.
format Online
Article
Text
id pubmed-10216992
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102169922023-05-27 Production and Characterization of ACE Inhibitory and Anti-Diabetic Peptides from Buffalo and Camel Milk Fermented with Lactobacillus and Yeast: A Comparative Analysis with In Vitro, In Silico, and Molecular Interaction Study Khakhariya, Ruchita Basaiawmoit, Bethsheba Sakure, Amar A. Maurya, Ruchika Bishnoi, Mahendra Kondepudi, Kanthi Kiran Padhi, Srichandan Rai, Amit Kumar Liu, Zhenbin Hati, Subrota Foods Article The investigation aimed at assessing a comparative study on the production and characterization of ACE inhibitory, anti-diabetic, and anti-inflammatory activities, along with the production of ACE inhibitory and anti-diabetic peptides through the fermentation of buffalo and camel milk by Limosilactobacillus fermentum (KGL4) and Saccharomyces cerevisiae (WBS2A). The angiotensin-converting enzyme (ACE) inhibitory and anti-diabetic properties were evaluated at particular time intervals (12, 24, 36, and 48 h) at 37 °C, and we discovered maximum activity at 37 °C after 48 h of incubation. The maximum ACE inhibitory, lipase inhibitory activities, alpha-glucosidase inhibitory, and alpha-amylase inhibitory activities were found in the fermented camel milk (77.96 ± 2.61, 73.85 ± 1.19, 85.37 ± 2.15, and 70.86 ± 1.02), as compared to the fermented buffalo milk (FBM) (75.25 ± 1.72, 61.79 ± 2.14, 80.09 ± 0.51, and 67.29 ± 1.75). Proteolytic activity was measured with different inoculation rates (1.5%, 2.0%, and 2.5%) and incubation times (12, 24, 36, and 48 h) to optimize the growth conditions. Maximum proteolysis was found at a 2.5% inoculation rate and at a 48 h incubation period in both fermented buffalo (9.14 ± 0.06) and camel milk (9.10 ± 0.17). SDS-PAGE and 2D gel electrophoresis were conducted for protein purification. The camel and buffalo milk that had not been fermented revealed protein bands ranging from 10 to 100 kDa and 10 to 75 kDa, respectively, whereas all the fermented samples showed bands ranging from 10 to 75 kDa. There were no visible protein bands in the permeates on SDS-PAGE. When fermented buffalo and camel milk were electrophoresed in 2D gel, 15 and 20 protein spots were detected, respectively. The protein spots in the 2D gel electrophoresis ranged in size from 20 to 75 kDa. To distinguish between different peptide fractions, water-soluble extract (WSE) fractions of ultrafiltration (3 and 10 kDa retentate and permeate) of fermented camel and buffalo milk were employed in RP-HPLC (reversed-phase high-performance liquid chromatography). The impact of fermented buffalo and camel milk on inflammation induced by LPS (lipopolysaccharide) was also investigated in the RAW 264.7 cell line. Novel peptide sequences with ACE inhibitory and anti-diabetic properties were also analyzed on the anti-hypertensive database (AHTDB) and bioactive peptide (BIOPEP) database. We found the sequences SCQAQPTTMTR, EMPFPK, TTMPLW, HPHPHLSFMAIPPK, FFNDKIAK, ALPMHIR, IPAVFK, LDQWLCEK, and AVPYPQR from the fermented buffalo milk and the sequences TDVMPQWW, EKTFLLYSCPHR, SSHPYLEQLY, IDSGLYLGSNYITAIR, and FDEFLSQSCAPGSDPR from the fermented camel milk. MDPI 2023-05-15 /pmc/articles/PMC10216992/ /pubmed/37238823 http://dx.doi.org/10.3390/foods12102006 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Khakhariya, Ruchita
Basaiawmoit, Bethsheba
Sakure, Amar A.
Maurya, Ruchika
Bishnoi, Mahendra
Kondepudi, Kanthi Kiran
Padhi, Srichandan
Rai, Amit Kumar
Liu, Zhenbin
Hati, Subrota
Production and Characterization of ACE Inhibitory and Anti-Diabetic Peptides from Buffalo and Camel Milk Fermented with Lactobacillus and Yeast: A Comparative Analysis with In Vitro, In Silico, and Molecular Interaction Study
title Production and Characterization of ACE Inhibitory and Anti-Diabetic Peptides from Buffalo and Camel Milk Fermented with Lactobacillus and Yeast: A Comparative Analysis with In Vitro, In Silico, and Molecular Interaction Study
title_full Production and Characterization of ACE Inhibitory and Anti-Diabetic Peptides from Buffalo and Camel Milk Fermented with Lactobacillus and Yeast: A Comparative Analysis with In Vitro, In Silico, and Molecular Interaction Study
title_fullStr Production and Characterization of ACE Inhibitory and Anti-Diabetic Peptides from Buffalo and Camel Milk Fermented with Lactobacillus and Yeast: A Comparative Analysis with In Vitro, In Silico, and Molecular Interaction Study
title_full_unstemmed Production and Characterization of ACE Inhibitory and Anti-Diabetic Peptides from Buffalo and Camel Milk Fermented with Lactobacillus and Yeast: A Comparative Analysis with In Vitro, In Silico, and Molecular Interaction Study
title_short Production and Characterization of ACE Inhibitory and Anti-Diabetic Peptides from Buffalo and Camel Milk Fermented with Lactobacillus and Yeast: A Comparative Analysis with In Vitro, In Silico, and Molecular Interaction Study
title_sort production and characterization of ace inhibitory and anti-diabetic peptides from buffalo and camel milk fermented with lactobacillus and yeast: a comparative analysis with in vitro, in silico, and molecular interaction study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216992/
https://www.ncbi.nlm.nih.gov/pubmed/37238823
http://dx.doi.org/10.3390/foods12102006
work_keys_str_mv AT khakhariyaruchita productionandcharacterizationofaceinhibitoryandantidiabeticpeptidesfrombuffaloandcamelmilkfermentedwithlactobacillusandyeastacomparativeanalysiswithinvitroinsilicoandmolecularinteractionstudy
AT basaiawmoitbethsheba productionandcharacterizationofaceinhibitoryandantidiabeticpeptidesfrombuffaloandcamelmilkfermentedwithlactobacillusandyeastacomparativeanalysiswithinvitroinsilicoandmolecularinteractionstudy
AT sakureamara productionandcharacterizationofaceinhibitoryandantidiabeticpeptidesfrombuffaloandcamelmilkfermentedwithlactobacillusandyeastacomparativeanalysiswithinvitroinsilicoandmolecularinteractionstudy
AT mauryaruchika productionandcharacterizationofaceinhibitoryandantidiabeticpeptidesfrombuffaloandcamelmilkfermentedwithlactobacillusandyeastacomparativeanalysiswithinvitroinsilicoandmolecularinteractionstudy
AT bishnoimahendra productionandcharacterizationofaceinhibitoryandantidiabeticpeptidesfrombuffaloandcamelmilkfermentedwithlactobacillusandyeastacomparativeanalysiswithinvitroinsilicoandmolecularinteractionstudy
AT kondepudikanthikiran productionandcharacterizationofaceinhibitoryandantidiabeticpeptidesfrombuffaloandcamelmilkfermentedwithlactobacillusandyeastacomparativeanalysiswithinvitroinsilicoandmolecularinteractionstudy
AT padhisrichandan productionandcharacterizationofaceinhibitoryandantidiabeticpeptidesfrombuffaloandcamelmilkfermentedwithlactobacillusandyeastacomparativeanalysiswithinvitroinsilicoandmolecularinteractionstudy
AT raiamitkumar productionandcharacterizationofaceinhibitoryandantidiabeticpeptidesfrombuffaloandcamelmilkfermentedwithlactobacillusandyeastacomparativeanalysiswithinvitroinsilicoandmolecularinteractionstudy
AT liuzhenbin productionandcharacterizationofaceinhibitoryandantidiabeticpeptidesfrombuffaloandcamelmilkfermentedwithlactobacillusandyeastacomparativeanalysiswithinvitroinsilicoandmolecularinteractionstudy
AT hatisubrota productionandcharacterizationofaceinhibitoryandantidiabeticpeptidesfrombuffaloandcamelmilkfermentedwithlactobacillusandyeastacomparativeanalysiswithinvitroinsilicoandmolecularinteractionstudy